Get Longevity Research Delivered Weekly
Join thousands of health professionals and curious minds. No spam, ever.
Enter your email to subscribe:
Your AI Longevity Team
Categories
TrendingLatest Summaries
Fresh from academic journals, YouTube, podcasts, and other sources
Scientists Probe Why Heart Attack Risk Persists After LDL Cholesterol Falls
Fat-carrying particles may damage arteries beyond cholesterol buildup, offering clues to heart attack risk that persists despite LDL control.
Even occasional marijuana use is tied to 40% higher odds of stroke
A survey of 440,000+ U.S. adults links even infrequent cannabis use to higher odds of a reported stroke history, though causation is unproven.
Oxaloacetate Shows Early Promise for Brain Fog After Breast Cancer
A small eight-week trial links oxaloacetate supplementation to better cognition and less fatigue in breast cancer survivors. Evidence remains preliminary.
New IgG4 Guidelines Update Treatment Advice but Expose Evidence Gaps
Experts agreed on 22 treatment statements for IgG4-related disease, but most still rest on low-level evidence despite recent clinical trials.
Testosterone Prescribing Rises Among Women as Recorded Monitoring Remains Low
A study of 10,185 women found rising testosterone prescribing, few recorded blood tests, and limited documentation of an evidence-based indication.
Cell reprogramming for aging and disease: animal evidence and early human testing
A 2026 review compares three ways to rewrite cell identity, from rejuvenating aged tissue to fighting cancer, and asks where each is safe enough for humans.
Natural Compound Targets C. difficile While Sparing Helpful Gut Bacteria in Early Tests
Argyrin B reduced C. difficile in infected mice and spared beneficial microbes in early tests. Human safety and effectiveness remain unproven.
Itaconate, an immune cell metabolite, rewires inflammation by chemically tagging key proteins
Macrophages make itaconate, which tags inflammatory proteins like NLRP3, STING1 and GPX4. This review maps how it controls inflammation and cell death.
GLP-1 Drugs Show Mixed Results for Reducing Pancreatic Fat
A six-study review finds promise but inconsistent human evidence that GLP-1 drugs reduce pancreatic fat, with no direct human data for semaglutide.
Intermittent fasting rebuilds the mitochondria of brown fat in obese mice
In obese mice, 8 weeks of 16:8 fasting restored brown fat mitochondrial shape, cristae structure, UCP1 content, and respiratory capacity.
New Framework Challenges Claims That Cosmetic Treatments Regenerate Skin
Smoother skin does not necessarily mean regenerated skin. A new framework separates cosmetic improvement from restoration of skin biology.
NAD+ Supplements Alone Fall Short Against Age-Related Muscle Loss
A review finds NAD+ precursors have not improved muscle mass or strength in older adults, while exercise combinations remain unproven.
Our Sponsors

Bioscope.AI
AI-Powered Precision Longevity for Physicians on the Leading Edge

Therabot
Therabot: Real Massage. Real Recovery.

Bioscope Foundry
We make it easy to launch your own precision longevity concierge practice

100 Is the New 30
How Playing the Symphony of Longevity Will Enable Us to Live Young for a Lifetime — Jeffrey Gladden, MD, FACC

MySuperFriends
A private world of AI companions — coaches, therapists, teachers, and guides who remember you and grow with you over time.















